MCID: VGN019
MIFTS: 35

Vaginal Discharge

Categories: Reproductive diseases

Aliases & Classifications for Vaginal Discharge

MalaCards integrated aliases for Vaginal Discharge:

Name: Vaginal Discharge 12 45 15 17

Classifications:



External Ids:

Disease Ontology 12 DOID:3767
MeSH 45 D019522
NCIt 51 C50795
SNOMED-CT 69 70856007
UMLS 74 C0227791

Summaries for Vaginal Discharge

Disease Ontology : 12 A vaginal disease that is characterized by the presence of discharge.

MalaCards based summary : Vaginal Discharge is related to endometritis and bacterial vaginosis. An important gene associated with Vaginal Discharge is DSPP (Dentin Sialophosphoprotein). The drugs Metronidazole and Iodine have been mentioned in the context of this disorder. Affiliated tissues include cervix, testes and skin.

Wikipedia : 77 Vaginal discharge is a mixture of liquid, cells, and bacteria that lubricates and protects the vagina.... more...

Related Diseases for Vaginal Discharge

Diseases related to Vaginal Discharge via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 56)
# Related Disease Score Top Affiliating Genes
1 endometritis 30.3 HP PGF
2 bacterial vaginosis 11.7
3 vaginitis 11.6
4 pelvic inflammatory disease 11.6
5 leukorrhea 11.6
6 trichomoniasis 11.5
7 chlamydia 11.5
8 trichomonas vaginalis trichomoniasis 11.1
9 fallopian tube carcinoma 11.1
10 vulvovaginal candidiasis 11.1
11 uterine carcinosarcoma 11.1
12 fitz-hugh-curtis syndrome 11.1
13 anhaptoglobinemia 10.1 HP TXNL4B
14 retinitis pigmentosa, y-linked 10.0 GYPC HPSE2
15 candidiasis 10.0
16 vulvovaginitis 10.0
17 endometrial disease 10.0 DSPP HP PGF
18 fallopian tube disease 10.0 EXTL3 MAPK8IP1
19 radiation cystitis 9.9 MAPK8IP1 PGF
20 vaginal disease 9.9 EXTL3 HP SPTB
21 hereditary elliptocytosis 9.9 GYPC SPTB
22 uterine anomalies 9.8 HPSE2 MAPK8IP1
23 congenital hemolytic anemia 9.8 HP SPTB
24 breast cancer 9.8
25 hypercarotenemia and vitamin a deficiency, autosomal dominant 9.8
26 klippel-trenaunay-weber syndrome 9.8
27 pemphigus vulgaris, familial 9.8
28 renal hypodysplasia/aplasia 1 9.8
29 uterus bicornis bicollis with partial vaginal septum and unilateral hematocolpos with ipsilateral renal agenesis 9.8
30 adenomyosis 9.8
31 cervical cancer 9.8
32 lymphangioleiomyomatosis 9.8
33 human immunodeficiency virus type 1 9.8
34 pemphigus vulgaris 9.8
35 sacrococcygeal teratoma 9.8
36 ulcerative colitis 9.8
37 colitis 9.8
38 keratomalacia 9.8
39 leiomyoma 9.8
40 acute cystitis 9.8
41 schistosomiasis 9.8
42 lymphangioma 9.8
43 ectropion 9.8
44 cystitis 9.8
45 cervicitis 9.8
46 papilloma 9.8
47 endometriosis 9.8
48 teratoma 9.8
49 adenoma 9.8
50 appendicitis 9.8

Graphical network of the top 20 diseases related to Vaginal Discharge:



Diseases related to Vaginal Discharge

Symptoms & Phenotypes for Vaginal Discharge

Drugs & Therapeutics for Vaginal Discharge

Drugs for Vaginal Discharge (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 131)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Metronidazole Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 443-48-1 4173
2
Iodine Approved, Investigational Phase 4,Phase 3 7553-56-2 807
3
Povidone Approved Phase 4,Phase 3 9003-39-8
4
Povidone-iodine Approved Phase 4,Phase 3 25655-41-8
5
Chlorhexidine Approved, Vet_approved Phase 4,Phase 3 55-56-1 2713 9552079
6
Clindamycin Approved, Vet_approved Phase 4,Phase 3 18323-44-9 29029
7
Clotrimazole Approved, Vet_approved Phase 4,Phase 3 23593-75-1 2812
8
Chlorquinaldol Approved Phase 4 72-80-0
9 Anti-Infective Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
10 Antiprotozoal Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
11 Antiparasitic Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
12 Anti-Bacterial Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
13 Anti-Infective Agents, Local Phase 4,Phase 3
14 Chlorhexidine gluconate Phase 4,Phase 3
15 cadexomer iodine Phase 4,Phase 3
16 Nutrients Phase 4,Phase 3,Not Applicable
17 Trace Elements Phase 4,Phase 3,Not Applicable
18 Plasma Substitutes Phase 4,Phase 3
19 Disinfectants Phase 4,Phase 3
20 Micronutrients Phase 4,Phase 3,Not Applicable
21 Blood Substitutes Phase 4,Phase 3
22 Dermatologic Agents Phase 4,Phase 3
23 Pharmaceutical Solutions Phase 4,Phase 2,Phase 3
24 Clindamycin palmitate Phase 4,Phase 3
25 Clindamycin phosphate Phase 4,Phase 3
26 Antibiotics, Antitubercular Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
27
Fluconazole Approved, Investigational Phase 3 86386-73-4 3365
28
Secnidazole Approved Phase 3 3366-95-8
29
Miconazole Approved, Investigational, Vet_approved Phase 3,Phase 2 22916-47-8 4189
30
Tinidazole Approved, Investigational Phase 3 19387-91-8 5479
31
Neomycin Approved, Vet_approved Phase 3 1404-04-2 8378
32
Polymyxin B Approved, Vet_approved Phase 3 1404-26-8
33
Nystatin Approved, Vet_approved Phase 3 1400-61-9 11953884
34
Aluminum sulfate Approved Phase 3 10043-01-3
35
Fluocinolone Acetonide Approved, Investigational, Vet_approved Phase 3 67-73-2 6215
36
Terconazole Approved Phase 3 67915-31-5 441383
37
Exemestane Approved, Investigational Phase 3 107868-30-4 60198
38
Tamoxifen Approved Phase 3,Phase 2 10540-29-1 2733526
39
Progesterone Approved, Vet_approved Phase 2, Phase 3,Not Applicable 57-83-0 5994
40
Imiquimod Approved, Investigational Phase 3 99011-02-6 57469
41
Betamethasone Approved, Vet_approved Phase 2, Phase 3 378-44-9 9782
42
Azithromycin Approved Phase 3 83905-01-5 55185 447043
43
Ketoconazole Approved, Investigational Phase 3 65277-42-1 47576
44
Levonorgestrel Approved, Investigational Phase 3 17489-40-6, 797-63-7 13109
45
Etonogestrel Approved, Investigational Phase 3 54048-10-1 40976 6917715
46
Polyestradiol phosphate Approved Phase 3,Phase 2,Not Applicable 28014-46-2
47
Desogestrel Approved Phase 3,Not Applicable 54024-22-5 40973
48
Estradiol Approved, Investigational, Vet_approved Phase 3,Phase 2,Not Applicable 50-28-2 5757
49
Ethinyl Estradiol Approved Phase 3,Not Applicable 57-63-6 5991
50
Ethanol Approved Phase 3 64-17-5 702

Interventional clinical trials:

(show top 50) (show all 93)
# Name Status NCT ID Phase Drugs
1 Tolerance of Chlorhexidine Gluconate Vaginal Cleansing Solution Completed NCT03305159 Phase 4 Povidone-Iodine;4% Chlorhexidine Gluconate
2 Examining the Impact of Tampon Use on the Vaginal Microbiota Completed NCT03346759 Phase 4
3 Safety and Tolerability of Metronidazole Gel 1.3% Completed NCT02392026 Phase 4 Metronidazole Gel
4 Comparison of Two Topical Formulations Containing Clindamycin and Clotrimazole in Patients With Vaginal Infections Completed NCT01697826 Phase 4 ClinSupV3 -soft gelatin capsule;ClinSupV3ER- Extended release tablet
5 Treatment Comparison of Antibiotics Versus Vaginal Lactic Acid in Non-pregnant Women With Acute Symptomatic Bacterial Vaginosis Recruiting NCT02042287 Phase 4 Metronidazole
6 Probiotics as Adjuvant Treatment for Bacterial Vaginosis Recruiting NCT03894813 Phase 4 "Probiotics" and "Metronidazole";Metronidazole Vaginal
7 The Efficacy of Tachosil® for Prevention of Hemorrhage After Loop Electrosurgical Excisional Procedure (LEEP) Active, not recruiting NCT02629510 Phase 4 Tachosil
8 Colposeptine for the Treatment of Bacterial Vaginosis Terminated NCT01153958 Phase 4 Colposeptine;Metronidazole
9 A Pilot Open-label Randomized Study of Lactofiltrum in Women With Bacterial Vaginosis Unknown status NCT01089348 Phase 2, Phase 3 Lactofiltrum + Metronidazole;Metronidazole
10 Safety and Clinical and Microbiological Efficacy of the Combination of Fluconazole and Secnidazole for the Treatment of Symptomatic Vaginal Discharge Completed NCT02111629 Phase 3 Fluconazole and Secnidazole
11 Study of the Management of Vaginal Discharge in West African Using Single Dose Treatments Completed NCT00313131 Phase 3 tinidazole+fluconazole vs metronidazole+clotrimazole
12 Assessment of the Efficacy of POLYGYNAX® in the Empirical Treatment of Infectious Vaginitis Completed NCT02515656 Phase 3 POLYGYNAX®;GYNODAKTARIN®;Placebo
13 A Multi-center, Double-blind, Randomized Study, Comparing Clindamycin Phosphate Vaginal Cream 2% (Watson Laboratories, Inc.) to Clindesse® (Ther-Rx™, Clindamyin Phosphate Vaginal Cream 2%) and Both Active Treatments to a Placebo Control in the Treatment of Bacterial Vaginosis in Non-pregnant Women Completed NCT02210689 Phase 3 clindamycin phosphate vaginal cream 2%
14 The Value of Bacterial Loads by Real Time PCR in Predicting Recurrence of Abnormal Vaginal Flora After Oral Metronidazole Therapy Completed NCT01287728 Phase 3 Treatment BY METROMIDAZOLE
15 Efficacy and Safety of Clino-san on Vaginal Dryness of Breast Cancer Patients Completed NCT00607295 Phase 3 clino-san vaginal lubricant
16 Diabetes Mellitus and Vulvovaginal Candidiasis Completed NCT00353561 Phase 3 Boric;Fluconazole
17 HerpeVac Trial for Young Women Completed NCT00057330 Phase 3
18 A Phase 3 Study of SYM-1219 Treatment of Women and Post-Menarchal Adolescent Girls With Bacterial Vaginosis Completed NCT02418845 Phase 3 SYM-1219;Placebo
19 A Study to Compare Efficacy and Safety of an Ovule Containing Terconazole, Clindamycin and Fluocinolone Versus an Ovule Containing Metronidazole, Nystatin and Fluocinolone in the Treatment of Secondary Vulvar/ or Vaginal Symptoms of Infectious Vaginitis/ and Infectious Vaginosis Completed NCT01867164 Phase 3 Gynoclin V;Vagitrol V
20 Pessary in Singleton Gestations With Short Cervix Without Prior Preterm Birth Completed NCT02716909 Phase 3
21 Randomized Trial Of Exemestane Versus Continued Tamoxifen In Postmenopausal Women With Early Breast Cancer Completed NCT00038467 Phase 3 Tamoxifen;Exemestane
22 The Study Of Fluconazole For Vulvovaginal Candidiasis Completed NCT01806623 Phase 3 Fluconazole
23 Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV) Completed NCT02237950 Phase 3 Metronidazole oral tablets 500mg;1% SPL7013 Gel;Placebo gel
24 Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV) Completed NCT02236156 Phase 3 Metronidazole oral tablets 500mg;1% SPL7013 Gel;Placebo gel
25 Imiquimod Treatment of Residual or Recurrent CIN Lesions: a Study Protocol Recruiting NCT02669459 Phase 3 Imiquimod
26 Does a Rescue Course of Betamethasone in Pregnant Women With PPROM Decrease Neonatal Morbidity? Recruiting NCT02939742 Phase 2, Phase 3 Betamethasone;Placebo
27 Pre-delivery Administration of Azithromycin to Prevent Neonatal Sepsis & Death Recruiting NCT03199547 Phase 3 Azithromycin;Placebo Oral Tablet
28 Ketoconazole Gel Versus Terconazole Cream for Vaginal Candidiasis Not yet recruiting NCT03473418 Phase 3 Ketoconazole;Terconazole
29 Cervical Pessary vs Vaginal Progesterone in Preventing Preterm Birth Among Women Presenting With Short Cervix: An Open-label Randomized Controlled Trial Not yet recruiting NCT02470676 Phase 2, Phase 3 Progesterone
30 Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring and Levonorgestrel-Ethinyl Estradiol Combined Oral Contraceptive in Adult Women at Risk for Pregnancy (MK-8342B-062) Terminated NCT02616146 Phase 3 ENG-E2 125 μg/300 μg vaginal ring;LNG-EE 150 μg/30 μg COC
31 A Comparison of Surgical Preparations and Wound Infection Rates for Elective Cesarean Sections Terminated NCT00528008 Phase 3
32 Efficacy and Safety of the Association of Clotrimazole and Metronidazole in the Treatment of Vaginal Discharge From Different Etiologies. Withdrawn NCT02713139 Phase 3 Clotrimazole + Metronidazole;Metronidazole;Clotrimazole
33 Efficacy, Safety LactiSal 1% Gel, LactSal 50 mg, Clotrimazole 100 mg Tablet in Treatment Vulvovaginal Candidiasis Withdrawn NCT02907307 Phase 3 Clotrimazole vaginal tablet 100mg
34 Intravaginal LACTIN-V for Prevention of Recurrent Urinary Tract Infection Completed NCT00305227 Phase 2 Lactin-V;Placebo
35 Metronidazole for Pulmonary Tuberculosis (South Korea) Completed NCT00425113 Phase 2 Metronidazole
36 A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis Completed NCT02147899 Phase 2 SYM-1219;Placebo
37 Safety and Efficacy of 5% Monolaurin Vaginal Gel Administered Intravaginally for the Treatment of Bacterial Vaginosis Completed NCT02709005 Phase 2 5% Monolaurin Vaginal Gel
38 Dose Ranging Study of Metronidazole Vaginal Gel in the Treatment of Bacterial Vaginosis Completed NCT01055106 Phase 2 GW05;GW05;GW05;Metronidazole
39 Efficacy Study of a Cervical Pessary Containing Progesterone for the Prevention of Preterm Delivery Completed NCT02225353 Phase 2 Progesterone Cervical Pessary 6.3 g;Progesterone 200 mg vaginal capsules;Progesterone Cervical Pessary 7.7 g
40 Tactile Electrosurgical Ablation in Cases of Dysfunctional Uterine Bleeding Completed NCT02248194 Phase 2
41 Randomized, Open-label Phase 2 Study of Oral AZD0914 in the Treatment of Gonorrhea Completed NCT02257918 Phase 2 AZD0914;Ceftriaxone
42 CAMB/MAT2203 in Patients With Mucocutaneous Candidiasis Recruiting NCT02629419 Phase 2 Amphotericin B
43 Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through the Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breast Recruiting NCT02993159 Phase 2 Afimoxifene;Tamoxifen Citrate
44 Vaginal Creams to Reduce Vaginal Erosion in Pessary Users Withdrawn NCT02316249 Phase 2 Estradiol
45 The Treatment Effect of Chinese Herbal Compound Ointment on Atrophic Vaginitis Unknown status NCT02733731 Phase 1 Chinese Herbal Compound Ointment;Estriol
46 Safety and Efficacy of Vaginal Microbiota Transplant (VMT) in Women With Bacterial Vaginosis (BV) Not yet recruiting NCT03769688 Phase 1 Cervicovaginal secretions;Metronidazole gel
47 The Presence of Microbes in the Sperm and Their Impact on Sperm Capacitation and IVF Treatment Unknown status NCT02585297
48 Diagnosing Bacterial Vaginosis/Vaginitis (BV) Using the Gynecologene Test Method Unknown status NCT02558179
49 Efficiency of Amnion Graft to Prevent Intrauterine Adhesions After Hysteroscopic Surgery Unknown status NCT02132104 Not Applicable Femoston
50 Conservative Management of Symptomatic Pelvic Organ Prolapse Using Vaginal Pessaries: Generation of a Standardized Management Protocol Unknown status NCT02113969 Not Applicable

Search NIH Clinical Center for Vaginal Discharge

Cochrane evidence based reviews: vaginal discharge

Genetic Tests for Vaginal Discharge

Anatomical Context for Vaginal Discharge

MalaCards organs/tissues related to Vaginal Discharge:

42
Cervix, Testes, Skin, Bone, Breast, Uterus, Kidney

Publications for Vaginal Discharge

Articles related to Vaginal Discharge:

(show top 50) (show all 351)
# Title Authors Year
1
Description of Janibacter massiliensis sp. nov., cultured from the vaginal discharge of a patient with bacterial vaginosis. ( 30798490 )
2019
2
Accuracy of leukocyte esterase test, endometrial cytology and vaginal discharge score for diagnosing postpartum reproductive tract health status in dairy cows at the moment of sampling, using a latent class model fit within a Bayesian framework. ( 30621886 )
2019
3
Draft Genome Sequence of Listeria monocytogenes CIIMS-NV-3, a Strain Isolated from Vaginal Discharge of a Woman from Central India. ( 30746522 )
2019
4
Vaginal Discharge in a Pre-pubertal Girl Posing a Diagnostic Challenge. ( 29872604 )
2018
5
Response of lactating dairy cows with or without purulent vaginal discharge to gonadotropin-releasing hormone and prostaglandin F2I+. ( 29385599 )
2018
6
The Etiology of Vaginal Discharge Syndrome in Zimbabwe: Results from the Zimbabwe STI Etiology Study. ( 29465674 )
2018
7
2018 European (IUSTI/WHO) International Union against sexually transmitted infections (IUSTI) World Health Organisation (WHO) guideline on the management of vaginal discharge. ( 30049258 )
2018
8
Relationship of vaginal discharge characteristics evaluated by Metricheck device to metabolic status in postpartum dairy cows. ( 30051632 )
2018
9
Chronic Vaginal Discharge After Uterine Fibroid Embolization. ( 30146213 )
2018
10
Randomized clinical trial to evaluate the efficacy of prostaglandin F2α to treat purulent vaginal discharge in lactating dairy cows. ( 30292549 )
2018
11
The demographic and clinical profiles of women presenting with vaginal discharge syndrome at primary care facilities in South Africa: Associations with age and implications for management. ( 30421718 )
2018
12
Risk factors associated with reproductive performance in Japanese dairy cows: vaginal discharge with flecks of pus or calving abnormality extend time to pregnancy. ( 30473578 )
2018
13
Effectiveness of intrauterine treatment with cephapirin in dairy cows with purulent vaginal discharge. ( 28043367 )
2017
14
Effects of intrauterine infusion of Escherichia coli lipopolysaccharide on uterine health, resolution of purulent vaginal discharge, and reproductive performance of lactating dairy cows. ( 28434752 )
2017
15
Purulent vaginal discharge in grazing dairy cows: Risk factors, reproductive performance, and prostaglandin F2I+ treatment. ( 28318582 )
2017
16
Sacrococcygeal teratoma presenting with vaginal discharge and polyp in an infant. ( 29269272 )
2017
17
Trichomonas vaginalis is very rare among women with vaginal discharge in Podlaskie province, Poland. ( 28612378 )
2017
18
Syndromic management of sexually transmissible infections in resource-poor settings: a systematic review with meta-analysis of the abnormal vaginal discharge flowchart for Neisseria gonorrhoea and Chlamydia trachomatis. ( 28838352 )
2017
19
Consider the Risk of Vesicouterine Fistula in the Event of Intermittent Fluid Vaginal Discharge after a Cesarean Section. ( 29090213 )
2017
20
Vaginal discharge concentrations of I^-human chorionic gonadotropin, creatinine, and urea for the diagnosis of premature rupture of membranes. ( 29197087 )
2017
21
An Insight to How Estate Women in Sri Lanka Manage Abnormal Vaginal Discharge. ( 28451566 )
2017
22
Effects of intrauterine infusion of Escherichia coli lipopolysaccharide on uterine mRNA gene expression and peripheral polymorphonuclear leukocytes in Jersey cows diagnosed with purulent vaginal discharge. ( 28434729 )
2017
23
Application of a bacteriological on-farm test to reduce antimicrobial usage in dairy cows with purulent vaginal discharge. ( 28237589 )
2017
24
Definitive Management of Persistent Vaginal Discharge Caused by Leiomyoma-endometrial Fistulas after Uterine Artery Embolization. ( 29223699 )
2017
25
Effect of diagnosis and treatment of clinical endometritis based on vaginal discharge score grading system in postpartum Holstein cows. ( 28740032 )
2017
26
Genetic and functional analysis of the bovine uterine microbiota. Part II: Purulent vaginal discharge versus healthy cows. ( 28259411 )
2017
27
Cervical cytopathological changes among women with vaginal discharge attending teaching hospital. ( 28469316 )
2017
28
Efficacy of Tamarindus indicus, Melia azadirach and Santalum album in syndromic management of abnormal vaginal discharge: A single-blind randomised controlled trial. ( 29257757 )
2017
29
Effect of Vaginal Hygiene Module to Attitudes and Behavior of Pathological Vaginal Discharge Prevention Among Female Adolescents in Slemanregency, Yogyakarta, Indonesia. ( 29282418 )
2017
30
Epidemiology and clinico-investigative study of organisms causing vaginal discharge. ( 28442807 )
2017
31
Primary chylous vaginal discharge demonstrated with noncontrast magnetic resonance lymphography. ( 28475249 )
2017
32
Effects of rumen-protected methionine and choline supplementation on vaginal discharge and uterine cytology of Holstein cows. ( 30255041 )
2017
33
High Risk Human Papilloma Virus Genotypes in Kurdistan Region in Patients with Vaginal Discharge. ( 27509950 )
2016
34
Low-Grade Appendiceal Mucinous Neoplasm Involving the Endometrium and Presenting with Mucinous Vaginal Discharge. ( 27843660 )
2016
35
Efficacy of syndromic management measured as symptomatic improvement in females with vaginal discharge syndrome. ( 27190409 )
2016
36
Variables associated with vaginal discharge after ultrasound-guided percutaneous microwave ablation for adenomyosis. ( 27087631 )
2016
37
Primary care management of women with persistent vaginal discharge. ( 27861272 )
2016
38
The Performance of the Vaginal Discharge Syndromic Management in Treating Vaginal and Cervical Infection: A Systematic Review and Meta-Analysis. ( 27706174 )
2016
39
Prepubertal vaginal discharge: Vaginoscopy to rule out foreign body. ( 27976557 )
2016
40
Study to Evaluate Targeted Management and Syndromic Management in Women Presenting with Abnormal Vaginal Discharge. ( 27651658 )
2016
41
Do female patients with nonpathological vaginal discharge need the same evaluation as for Dhat syndrome in males? ( 26985107 )
2016
42
Utility of Laboratory Diagnosis for Confirmation of the Syndromic Case Management in Married Indian Women with Vaginal Discharge. ( 27833516 )
2016
43
Co-infection with Bovine Herpesvirus 4 and Histophilus somni Significantly Extends the Service Period in Dairy Cattle with Purulent Vaginal Discharge. ( 26690881 )
2016
44
Sore throat A^ vaginal discharge A^ labial ulcer A^ Dx? ( 27474821 )
2016
45
Chronic vaginal discharge due to vesicovaginal fistula. ( 25876713 )
2015
46
A 78-Year-Old Woman with Fecaloid Vaginal Discharge. ( 26495410 )
2015
47
Randomized clinical trial of intrauterine cephapirin infusion in dairy cows for the treatment of purulent vaginal discharge and cytological endometritis. ( 26210270 )
2015
48
Alpha-fetoprotein as a tool to distinguish amniotic fluid from urine, vaginal discharge, and semen. ( 25569004 )
2015
49
Technical note: Intraobserver, interobserver, and test-retest reliabilities of an assessment of vaginal discharge from cows with and without acute puerperal metritis. ( 26026759 )
2015
50
Utility of microbiological profile of symptomatic vaginal discharge in rural women of reproductive age group. ( 25954668 )
2015

Variations for Vaginal Discharge

Expression for Vaginal Discharge

Search GEO for disease gene expression data for Vaginal Discharge.

Pathways for Vaginal Discharge

GO Terms for Vaginal Discharge

Biological processes related to Vaginal Discharge according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cellular response to hormone stimulus GO:0032870 8.62 DSPP PGF

Sources for Vaginal Discharge

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....